Hiroaki Kataoka

10.2k total citations · 2 hit papers
295 papers, 8.1k citations indexed

About

Hiroaki Kataoka is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Hiroaki Kataoka has authored 295 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Molecular Biology, 88 papers in Hepatology and 80 papers in Oncology. Recurrent topics in Hiroaki Kataoka's work include Liver physiology and pathology (78 papers), Peptidase Inhibition and Analysis (27 papers) and Protease and Inhibitor Mechanisms (26 papers). Hiroaki Kataoka is often cited by papers focused on Liver physiology and pathology (78 papers), Peptidase Inhibition and Analysis (27 papers) and Protease and Inhibitor Mechanisms (26 papers). Hiroaki Kataoka collaborates with scholars based in Japan, United States and France. Hiroaki Kataoka's co-authors include Masashi Koono, Hiroshi Itoh, Kazuki Nabeshima, Tsuyoshi Fukushima, Chitra Biswas, Makiko Kawaguchi, Hiroyuki Tanaka, Toshiya Nakamura, Huichen Guo and Takeshi Shimomura and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hiroaki Kataoka

283 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin

1985 726 citations Hiroaki Kataoka et al. profile →
The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily.

1995 634 citations Hiroaki Kataoka et al. PubMed profile →

Peers

Countries citing papers authored by Hiroaki Kataoka

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Kataoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kataoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kataoka more than expected).

Fields of papers citing papers by Hiroaki Kataoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Kataoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kataoka. The network helps show where Hiroaki Kataoka may publish in the future.

Co-authorship network of co-authors of Hiroaki Kataoka

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Kataoka. A scholar is included among the top collaborators of Hiroaki Kataoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Kataoka. Hiroaki Kataoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A new type of sulfation reaction: C-sulfonation for α,β-unsaturated carbonyl groups by a novel sulfotransferase SULT7A1 2024 ·PNAS Nexus ·Katsuhisa Kurogi, Yoichi Sakakibara, (unknown), Yoshimitsu Kakuta, (unknown), Takamasa Teramoto, Tsuyoshi Fukushima, Takeshi Bamba, Jin Matsumoto, Eiichiro Fukusaki, Hiroaki Kataoka, Masahito Suiko	3
2	Adrenomedullin alleviates mucosal injury in experimental colitis and increases claudin‐4 expression in the colonic epithelium 2023 ·FEBS Open Bio ·Makiko Kawaguchi, Hiroaki Kataoka, (unknown), (unknown), Sayaka Nagata, Kazuo Kitamura, Tsuyoshi Fukushima	0
3	Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells 2022 ·Cancer Science ·(unknown), Koji Yamamoto, Makiko Kawaguchi, (unknown), Tsuyoshi Fukushima, (unknown), Hiroyuki Tanaka, (unknown), Hiroaki Kataoka	2
4	Decreased prostasin expression is associated with aggressiveness of oral squamous cell carcinoma 2021 ·Human Cell ·Koji Yamamoto, (unknown), Makiko Kawaguchi, (unknown), (unknown), Hiroaki Kataoka, Takeshi Kaneuji, Yoshihiro Yamashita, Tsuyoshi Fukushima	2
5	Severe Fever with Thrombocytopenia Syndrome Accompanied by Invasive Pulmonary Aspergillosis: An Autopsy Case 2021 ·Viruses ·(unknown), Takeshi Kawaguchi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ichiro Takajo, (unknown), Tsuyoshi Fukushima, Hiroaki Kataoka, Tadaki Suzuki, Akihiko Okayama, Kunihiko Umekita	13
6	Retinoic acid attenuates nuclear factor kappaB mediated induction of NLRP3 inflammasome 2021 ·Pharmacological Reports ·(unknown), Radha Madhyastha, Harishkumar Madhyastha, (unknown), Masugi Maruyama, Yuichi Nakajima, Hiroaki Kataoka, Nozomi Watanabe	5
7	Protease‐activated receptor‐2 accelerates intestinal tumor formation through activation of nuclear factor‐κB signaling and tumor angiogenesis in Apc^Min/+ mice 2020 ·Cancer Science ·Makiko Kawaguchi, Koji Yamamoto, Hiroaki Kataoka, (unknown), (unknown), (unknown), Takahiro Nishida, Eric Camerer, Tsuyoshi Fukushima	15
8	Proteolytic cleavage of Podocin by Matriptase exacerbates podocyte injury 2020 ·Journal of Biological Chemistry ·S. Ozawa, (unknown), (unknown), Motoko Yanagita, Kiyoshi Mori, Katsuhiko Asanuma, Nobuyuki Kajiwara, Kazuyuki Hayashi, Hiroshi Ohashi, Masato Kasahara, Hideki Yokoi, Hiroaki Kataoka, Eiichiro Mori, Takahiko Nakagawa	6
9	A Nucleoside Derivative 5-Vinyluridine (VrU) for Imaging RNA in Cells and Animals 2019 ·Bioconjugate Chemistry ·Hongshan Liu, Takumi Ishizuka, Makiko Kawaguchi, Ryuichi Nishii, Hiroaki Kataoka, Yan Xu	19
10	Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair 2018 ·International Journal of Molecular Sciences ·Tsuyoshi Fukushima, Shuichiro Uchiyama, Hiroyuki Tanaka, Hiroaki Kataoka	62
11	Aberrant methylation and silencing of the SPINT2 gene in high‐grade gliomas 2018 ·Cancer Science ·Tsuyoshi Fukushima, Makiko Kawaguchi, Koji Yamamoto, (unknown), (unknown), (unknown), Yuka Takezaki, Hiroshi Itoh, Hideo Takeshima, Hiroaki Kataoka	12
12	Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine 2018 ·Communications Biology ·Makiko Kawaguchi, Koji Yamamoto, Naoki Takeda, Tsuyoshi Fukushima, (unknown), Katsuaki Sato, Kenichiro Kitamura, Yoshitaka Hippo, James W. Janetka, Hiroaki Kataoka	20
13	Outcome of fertility-sparing treatment with medroxyprogesterone acetate for atypical hyperplasia and endometrial carcinoma in young Japanese women. 2014 ·PubMed ·Hiroaki Kataoka, Toshihiko Mori, Takeshi Yamamoto, (unknown), Haruo Kuroboshi, (unknown), Kazuhiro Iwasaku, Jo Kitawaki	6
14	Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis 2013 ·Cancer Research ·(unknown), Makiko Kawaguchi, Tsuyoshi Fukushima, (unknown), Kenji Yorita, Hiroyuki Tanaka, Motoharu Seiki, Haruhiko Inatsu, Kazuo Kitamura, Hiroaki Kataoka	36
15	PRIMARY ACCESSORY BREAST CANCER IN A MALE-CASE REPORT AND REVIEW OF THE LITERATURE- 2011 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Nobuhiro Shibata, Naoki Maehara, Kenji Yorita, (unknown), Hideki Hidaka, Hiroaki Kataoka, Kazuo Chijiiwa	0
16	Hepatocyte Growth Factor Activator Inhibitor Type 1 Regulates Epithelial to Mesenchymal Transition through Membrane-Bound Serine Proteinases 2009 ·Cancer Research ·Haixia Cheng, Tsuyoshi Fukushima, Nobuyasu Takahashi, Hiroyuki Tanaka, Hiroaki Kataoka	66
17	Inferior Bile Duct Cancer with Sarcomatous Change: A Case Report 2007 ·The Japanese Journal of Gastroenterological Surgery ·Koki Nagaike, Kazuo Chijiiwa, Kotaro Matsumoto, Masahide Hiyoshi, Motoaki Nagano, Naoya İmamura, Jiro Ohuchida, Hiroaki Kataoka	3
18	Effect of hepatocyte growth factor on endogenous hepatocarcinogenesis in rats fed a choline-deficient L-amino acid-defined diet 2006 ·Oncology Reports ·(unknown), Akihiro Moriuchi, Akio Ido, Masatsugu Numata, (unknown), Kazunori Kusumoto, Satoru Hasuike, (unknown), Kenji Nagata, Yutaka Akiyama, Hirofumi Uto, Hiroaki Kataoka, Hirohito Tsubouchi	4
19	Follicular Dendritic Cells Catalyze Hepatocyte Growth Factor (HGF) Activation in the Germinal Center Microenvironment by Secreting the Serine Protease HGF Activator 2005 ·The Journal of Immunology ·Esther P.M. Tjin, Richard J. Bende, Patrick W.B. Derksen, (unknown), Hiroaki Kataoka, Marcel Spaargaren, Steven T. Pals	23
20	Microglial activation in the brains of a novel epileptic mutant, ihara epileptic rat (IER). 1999 ·Epilepsia ·Hiroaki Kataoka, (unknown), (unknown), Yoneko Hayase, Manabu Sasahara, Ryuzo Torii, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact